Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
85.25 USD | -0.61% | -1.02% | +19.35% |
13/05 | Ligand Pharmaceuticals Insider Sold Shares Worth $830,449, According to a Recent SEC Filing | MT |
08/05 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.35% | 154.07Cr | |
+33.53% | 71TCr | |
+30.91% | 60TCr | |
-2.18% | 37TCr | |
+20.46% | 33TCr | |
+4.99% | 29TCr | |
+14.40% | 24TCr | |
+9.21% | 21TCr | |
-3.68% | 20TCr | |
+8.59% | 17TCr |
- Stock Market
- Equities
- LGND Stock
- News Ligand Pharmaceuticals Incorporated
- Ligand Pharmaceuticals to Spin Off OmniAb Business Via Merger With Avista Public Acquisition